Today: 27 April 2026
IBM stock dips on ex-dividend day as it rolls out agentic AI FlashSystem storage
10 February 2026
2 mins read

IBM stock dips on ex-dividend day as it rolls out agentic AI FlashSystem storage

New York, Feb 10, 2026, 14:13 EST — Regular session

  • IBM slipped roughly 1.4% in afternoon trading, trailing a broader market that was holding steady.
  • Tuesday saw the stock go ex-dividend. IBM, for its part, introduced a fresh FlashSystem storage lineup, touting “autonomous” operations.
  • Investors are eyeing the new hardware-and-software bundle to see if it can actually drive enterprise AI and security spending.

Shares of International Business Machines Corp slipped 1.4% to $292.19 Tuesday, pulling back from Monday’s $296.34 close. The drop followed IBM going ex-dividend and highlighting a storage refresh focused on its so-called “agentic AI.”

Dividend timing is in focus because it can cloud what’s happening on the tape. When the ex-dividend date hits, the stock trades without the next payout attached — and you’ll often see prices slip, typically by about the size of the dividend, as that value moves from seller to buyer.

IBM wants investors to pay attention to execution, not just the nuts and bolts. The company has relied on consistent cash payouts and stable enterprise contracts, while pushing its infrastructure products as essential for AI adoption in the business world—and as a defense against ransomware.

IBM rolled out its latest storage lineup Tuesday, announcing the FlashSystem 5600, 7600, and 9600 models, plus a new AI-driven feature called “FlashSystem.ai.” The company bills these as enterprise-grade, with AI agents that take on monitoring and troubleshooting duties—promising up to 90% less manual work on storage management, and ransomware detection in under a minute. General availability lands March 6. “Always-available” storage remains the target, according to Sam Werner, IBM’s head of storage. IDC’s Natalya Yezhkova cited automation and added security as notable upgrades. IBM Newsroom

Agentic AI boils down to software that acts, not just responds. IBM says its agents keep an eye on system signals, spot threats, and suggest ways to recover, aiming to shrink the distance between an “alert” and an actual “fix” for IT teams already running thin.

The wider market barely budged. SPY tracked the S&P 500 with no real movement. QQQ slipped a touch, DIA—tied to the Dow—managed a small gain. Microsoft and Oracle both advanced. IBM, on the other hand, trailed the pack.

IBM’s board signed off on a regular quarterly cash dividend of $1.68 a share, with the payout set for March 10 to holders of record as of Feb. 10. The company noted this keeps its uninterrupted streak of quarterly dividends going since 1916.

The $1.68 dividend barely registers against Tuesday’s roughly $4 decline. That steep drop goes beyond any simple ex-dividend date adjustment, with shares giving up more than the payout during the session.

Still, IBM’s pitch isn’t without downsides. Those promised savings and detection gains hinge on lab conditions and disclaimers, and large clients often drag their feet when automation gets near essential data or security layers. Storage remains a crowded field—NetApp, Dell, Hewlett Packard Enterprise, all circling the same spending.

Investors have their eyes on initial uptake as IBM’s new FlashSystem lineup hits general availability in early March. The company is set to post its next quarterly update April 22, according to its preliminary schedule.

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Bloom Energy stock turns choppy as SEC filing details Oracle warrant and Brookfield AI financing
Previous Story

Bloom Energy stock turns choppy as SEC filing details Oracle warrant and Brookfield AI financing

DoorDash stock slips as U.S. retail sales stall — earnings next week loom
Next Story

DoorDash stock slips as U.S. retail sales stall — earnings next week loom

Go toTop